These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 26315756)

  • 1. Highly active antiretroviral therapy and dyslipidemia in people living with HIV/AIDS in Fako Division, South West Region of Cameroon.
    Nsagha DS; Weledji EP; Assob NJ; Njunda LA; Tanue EA; Kibu OD; Ayima CW; Ngowe MN
    BMC Cardiovasc Disord; 2015 Aug; 15():95. PubMed ID: 26315756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral treatment associated hyperglycemia and dyslipidemia among HIV infected patients at Burayu Health Center, Addis Ababa, Ethiopia: a cross-sectional comparative study.
    Abebe M; Kinde S; Belay G; Gebreegziabxier A; Challa F; Gebeyehu T; Nigussie P; Tegbaru B
    BMC Res Notes; 2014 Jun; 7():380. PubMed ID: 24950924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lipid profile of HIV-infected patients receiving antiretroviral therapy in a rural Cameroonian population.
    Bekolo CE; Nguena MB; Ewane L; Bekoule PS; Kollo B
    BMC Public Health; 2014 Mar; 14():236. PubMed ID: 24606888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in lipid profile over 24 months among adults on first-line highly active antiretroviral therapy in the home-based AIDS care program in rural Uganda.
    Buchacz K; Weidle PJ; Moore D; Were W; Mermin J; Downing R; Kigozi A; Borkowf CB; Ndazima V; Brooks JT
    J Acquir Immune Defic Syndr; 2008 Mar; 47(3):304-11. PubMed ID: 18398971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyslipidemia and associated risk factors among HIV/AIDS patients on HAART in Asmara, Eritrea.
    Achila OO; Abrhaley F; Kesete Y; Tesfaldet F; Alazar F; Fisshaye L; Gebremeskel L; Mehari R; Andemichael D
    PLoS One; 2022; 17(7):e0270838. PubMed ID: 35776747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HAART, DOTS and renal disease of patients co-infected with HIV/AIDS and TB in the South West Region of Cameroon.
    Nsagha DS; Pokam BT; Assob JC; Njunda AL; Kibu OD; Tanue EA; Ayima CW; Weledji PE
    BMC Public Health; 2015 Oct; 15():1040. PubMed ID: 26452646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of dyslipidemia and dysglycaemia in HIV infected patients.
    Manuthu EM; Joshi MD; Lule GN; Karari E
    East Afr Med J; 2008 Jan; 85(1):10-7. PubMed ID: 18543521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of dyslipidemia among human immunodeficiency virus infected Nigerians.
    Muhammad S; Sani MU; Okeahialam BN
    Ann Afr Med; 2013; 12(1):24-8. PubMed ID: 23480991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of dyslipidemia among HIV-infected patients using first-line highly active antiretroviral therapy in Southern Ethiopia: a cross-sectional comparative group study.
    Tadewos A; Addis Z; Ambachew H; Banerjee S
    AIDS Res Ther; 2012 Oct; 9(1):31. PubMed ID: 23095661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyslipidemia in AIDS patients on highly active antiretroviral therapy.
    Nery MW; Martelli CM; Turchi MD
    Braz J Infect Dis; 2011; 15(2):151-5. PubMed ID: 21503402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-line antiretroviral therapy and dyslipidemia in people living with HIV-1 in Cameroon: a cross-sectional study.
    Pefura Yone EW; Betyoumin AF; Kengne AP; Kaze Folefack FJ; Ngogang J
    AIDS Res Ther; 2011 Sep; 8():33. PubMed ID: 21943115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Hypertension in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) Compared with HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon.
    Dimala CA; Atashili J; Mbuagbaw JC; Wilfred A; Monekosso GL
    PLoS One; 2016; 11(2):e0148100. PubMed ID: 26862763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden of metabolic syndrome among HIV-infected patients in Southern Ethiopia.
    Tesfaye DY; Kinde S; Medhin G; Megerssa YC; Tadewos A; Tadesse E; Shimelis T
    Diabetes Metab Syndr; 2014; 8(2):102-7. PubMed ID: 24907175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary intervention prevents dyslipidemia associated with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected individuals: a randomized trial.
    Lazzaretti RK; Kuhmmer R; Sprinz E; Polanczyk CA; Ribeiro JP
    J Am Coll Cardiol; 2012 Mar; 59(11):979-88. PubMed ID: 22402068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effectiveness of a Bioactive Food Compound in the Lipid Control of Individuals with HIV/AIDS.
    Dos Santos Ferreira R; de Cássia Avellaneda Guimarães R; Jardim Cury Pontes ER; Aragão do Nascimento V; Aiko Hiane P
    Nutrients; 2016 Oct; 8(10):. PubMed ID: 27740592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Interleukin-6 and Weight Loss in Antiretroviral-naïve and Antiretroviral-treated Patients with HIV/AIDS: Relationships and Predictors.
    Adedeji TA; Adedeji NO; Ajeigbe AK; Smith OS; Jeje OA; Fawale MB; Ajose AO; Adebisi SA; Akande AA; Okesina BA
    Curr HIV Res; 2022; 20(6):441-456. PubMed ID: 36056868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparison of the Diabetes Risk Score in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) and HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon.
    Dimala CA; Atashili J; Mbuagbaw JC; Wilfred A; Monekosso GL
    PLoS One; 2016; 11(5):e0155560. PubMed ID: 27195956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained improvement of dyslipidaemia in HAART-treated patients replacing stavudine with tenofovir.
    Llibre JM; Domingo P; Palacios R; Santos J; Pérez-Elías MJ; Sánchez-de la Rosa R; Miralles C; Antela A; Moreno S;
    AIDS; 2006 Jun; 20(10):1407-14. PubMed ID: 16791015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lipodystrophy and echographic hepatic steatosis in HIV-positive patients under highly active antiretroviral therapy (HAART) in Yaounde (Cameroon)].
    Ongolo-Zogo P; Nkodo Mbia N; Mvogo Minkala TL; Biwole Sida M; Kouanfack C; Nko Amvene S
    Bull Soc Pathol Exot; 2012 Dec; 105(5):353-60. PubMed ID: 22886433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum lipid profile in highly active antiretroviral therapy-naïve HIV-infected patients in Cameroon: a case-control study.
    Nguemaïm NF; Mbuagbaw J; Nkoa T; Alemnji G; Této G; Fanhi TC; Asonganyi T; Samé-Ekobo A
    HIV Med; 2010 Jul; 11(6):353-9. PubMed ID: 20345886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.